Global Stereotactic Radiosurgery (SRS) Systems Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033

Stereotactic Radiosurgery (SRS) Systems Market Size

• The global stereotactic radiosurgery (SRS) systems market size was valued at USD 4.8 billion in 2025and is expected to reach USD 9.6 billion by 2033, at a CAGR of 9.1% during the forecast period
• Growth is driven by increasing prevalence of neurological disorders, brain tumors, and rising demand for non-invasive treatment procedures
• Expanding adoption of precision radiation therapies and advancements in image-guided radiotherapy technologies are accelerating market expansion

Stereotactic Radiosurgery (SRS) Systems Market Analysis

• Stereotactic radiosurgery (SRS) systems, which deliver highly focused radiation beams to treat tumors and functional abnormalities in the brain and body, are becoming essential in modern oncology and neurosurgery due to their precision, reduced treatment time, and non-invasive nature
• The escalating demand for SRS systems is primarily driven by increasing incidence of cancer (especially brain metastases), rising geriatric population, and growing preference for outpatient and minimally invasive treatment modalities
• North America dominated the SRS systems market with the largest revenue share of 38.2% in 2025, supported by advanced healthcare infrastructure, high adoption of innovative radiotherapy systems, and strong presence of key market players
• Asia-Pacific is expected to be the fastest-growing region during the forecast period due to increasing cancer burden, improving healthcare access, and growing investments in radiotherapy infrastructure across countries such as China, India, and Japan
• The linear accelerator (LINAC)-based systems segment dominated the market with a share of 46.5% in 2025, driven by widespread availability, cost-effectiveness, and versatility across multiple cancer treatments.

Report Scope and Stereotactic Radiosurgery (SRS) Systems Market Segmentation

Stereotactic Radiosurgery (SRS) Systems Market Trends

“Rising Adoption of Precision, Image-Guided, and Minimally Invasive Radiosurgery Technologies”

• A significant and accelerating trend in the global stereotactic radiosurgery (SRS) systems market is the growing shift toward high-precision, image-guided, and minimally invasive radiation therapies that enhance treatment accuracy while minimizing damage to surrounding healthy tissues across multiple clinical applications.
• For instance, companies such as Elekta AB and Accuray Incorporated are increasingly developing advanced SRS systems with robotic guidance, real-time imaging, and AI-enabled treatment planning to improve clinical outcomes in oncology and neurosurgery.
• Technological advancements in imaging integration, motion tracking, and radiation delivery are enabling the development of SRS systems with improved targeting accuracy, treatment efficiency, and patient safety across a wide range of tumor indications.
• The increasing adoption of non-invasive outpatient treatment procedures is supporting the demand for SRS systems that reduce hospitalization time and enhance patient convenience and recovery outcomes.
• This trend toward precision-driven and high-performance radiosurgery solutions is reshaping clinical practices, regulatory expectations, and treatment protocols across oncology and neurology treatment centers.
• The demand for advanced SRS systems with enhanced automation, workflow efficiency, and reduced treatment time is growing rapidly across both developed and emerging healthcare markets, driven by increasing cancer burden and technological adoption.
• Increasing integration of digital technologies, artificial intelligence, and real-time imaging is gaining traction due to rising demand for personalized and accurate cancer treatment solutions across global healthcare systems.

Stereotactic Radiosurgery (SRS) Systems Market Dynamics

Driver

“Rising Prevalence of Cancer and Growing Demand for Non-Invasive Treatment Solutions”

• The increasing global prevalence of cancer, particularly brain tumors and metastatic conditions, coupled with rising demand for non-invasive and precise treatment options, is a major driver fueling the growth of the stereotactic radiosurgery (SRS) systems market globally.
• For instance, healthcare systems in regions such as North America and Europe are increasingly adopting advanced radiotherapy technologies to improve treatment outcomes and reduce surgical risks.
• As healthcare providers focus more on improving patient outcomes and reducing treatment complications, SRS systems offer high precision, minimal invasiveness, and reduced recovery time compared to conventional surgical procedures.
• Furthermore, the growing shift toward outpatient and minimally invasive treatment approaches, supported by advancements in medical technology and increasing patient awareness, is accelerating the adoption of SRS systems across healthcare facilities.
• The versatility of SRS systems across applications such as brain tumors, spine disorders, and functional neurological conditions, along with their ability to enhance treatment accuracy and efficiency, is driving widespread adoption.
• Expanding healthcare infrastructure and increasing investments in oncology treatment facilities in emerging economies are further supporting market expansion.
• Government initiatives and funding programs focused on cancer care and advanced medical technologies are accelerating investments and deployment of SRS systems globally.

Restraint/Challenge

“High Capital Cost and Infrastructure Requirements”

• Challenges related to the high cost of SRS systems and associated infrastructure requirements pose significant barriers to large-scale adoption, particularly in cost-sensitive healthcare markets.
• For instance, installation of SRS systems requires specialized facilities, radiation shielding, and skilled professionals, leading to high initial capital investment and operational costs.
• Addressing these challenges through technological advancements, cost optimization, and improved accessibility is critical for enhancing market penetration and adoption rates.
• While demand for advanced radiosurgery solutions is increasing, certain healthcare facilities may face limitations in terms of budget, infrastructure, and technical expertise, restricting widespread implementation.
• Overcoming these challenges through continuous innovation, training programs, and partnerships will be essential for long-term market growth, while cost constraints may impact adoption in developing regions.
• Regulatory requirements and reimbursement limitations can also increase complexity and affect investment decisions, potentially influencing market expansion timelines.

Stereotactic Radiosurgery (SRS) Systems Market Scope

The market is segmented on the basis of product type, technology, application, and end user..

• By Product Type

On the basis of product type, the global stereotactic radiosurgery (SRS) systems market is segmented into Gamma Knife systems, Linear Accelerator (LINAC)-based systems, CyberKnife systems, proton beam systems, and others. The Linear Accelerator (LINAC)-based systems segment dominated the market with the largest revenue share of 46.5% in 2025, driven by their widespread availability, cost-effectiveness, and versatility in treating a broad range of cancers, including brain, lung, and prostate tumors. LINAC systems are widely preferred due to their ability to perform both stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT), along with continuous technological advancements in imaging and treatment planning, which further strengthen segment dominance globally.

The CyberKnife systems segment is expected to witness the fastest growth during the forecast period, fueled by increasing demand for robotic radiosurgery solutions with real-time tumor tracking and high precision. Growing adoption in complex tumor treatments and advancements in robotic and AI-integrated technologies are significantly enhancing treatment accuracy and expanding application scope, thereby accelerating segment growth globally.

• By Technology

On the basis of technology, the market is segmented into frame-based SRS, frameless SRS, image-guided SRS, and robotic SRS. The frame-based SRS segment dominated the market with the largest revenue share in 2025, supported by its high accuracy and long-standing clinical reliability in treating intracranial lesions. It is widely used in Gamma Knife procedures due to its precision in targeting brain tumors.

The frameless SRS segment is expected to witness the fastest growth during the forecast period, driven by increasing preference for non-invasive and patient-friendly treatment approaches. Advancements in imaging and motion management technologies are enabling high precision without the need for rigid frames, improving patient comfort and expanding adoption across healthcare facilities.

• By Application

On the basis of application, the stereotactic radiosurgery (SRS) systems market is segmented into brain tumors, spine tumors, lung cancer, prostate cancer, arteriovenous malformations (AVMs), functional disorders, and others. The brain tumors segment dominated the market with the largest revenue share of 41.8% in 2025, supported by the high prevalence of brain metastases and strong clinical effectiveness of SRS in treating intracranial conditions with minimal invasiveness. Increasing use of SRS as a primary or adjunct therapy in neurosurgical treatments is further strengthening segment dominance.

The lung cancer segment is expected to witness the fastest growth during the forecast period, driven by rising global incidence of lung cancer and increasing adoption of stereotactic body radiotherapy (SBRT) for early-stage tumors. Technological advancements in tumor tracking and radiation delivery are further accelerating segment growth globally

• By End User

On the basis of end user, the market is segmented into hospitals, cancer treatment centers, specialty clinics, and ambulatory surgical centers. The hospitals segment dominated the market with the largest revenue share in 2025, driven by the availability of advanced infrastructure, skilled professionals, and integrated oncology treatment facilities. Hospitals remain the primary centers for complex radiosurgery procedures due to their comprehensive capabilities.

The cancer treatment centers segment is expected to witness the fastest growth during the forecast period, fueled by increasing establishment of specialized oncology facilities and growing demand for dedicated cancer care services. These centers focus on advanced treatment technologies and personalized care, which is driving their rapid adoption globally.

Stereotactic Radiosurgery (SRS) Systems Market Regional Analysis

• North America dominated the stereotactic radiosurgery (SRS) systems market with the largest revenue share of 38.2% in 2025, supported by advanced healthcare infrastructure, high adoption of precision radiotherapy technologies, and strong presence of leading market players, with the U.S. being the major contributor to market growth
• Healthcare providers and oncology centers in the region place significant emphasis on early diagnosis, advanced treatment technologies, and minimally invasive procedures, leading to widespread utilization of SRS systems across hospitals and specialized cancer treatment centers
• This strong market position is further supported by high healthcare expenditure, favorable reimbursement policies, and continuous technological advancements, establishing SRS systems as critical components in modern oncology treatment across the region

U.S. Stereotactic Radiosurgery (SRS) Systems Market Insight

The U.S. stereotactic radiosurgery (SRS) systems market captured the largest revenue share of 79.2% in 2025 within North America, driven by advanced healthcare infrastructure, high adoption of innovative radiotherapy technologies, and strong presence of key market players such as Elekta AB, Varian Medical Systems, and Accuray Incorporated. The increasing prevalence of cancer and growing demand for minimally invasive treatment procedures continue to propel market growth. Moreover, strong reimbursement frameworks and continuous technological advancements in imaging and radiation delivery significantly contribute to sustained market expansion..

Europe Stereotactic Radiosurgery (SRS) Systems Market Insight

The Europe stereotactic radiosurgery (SRS) systems market is projected to expand at a steady CAGR throughout the forecast period, primarily driven by well-established healthcare systems and increasing focus on precision medicine and advanced cancer treatment technologies. Growing adoption of stereotactic radiosurgery across oncology centers is accelerating demand for high-precision radiotherapy solutions. European healthcare systems emphasize quality care, technological innovation, and patient safety, fostering consistent adoption across hospitals and specialized treatment centers. Growth is supported by favorable regulatory frameworks and increasing investments in advanced medical technologies.

U.K. Stereotactic Radiosurgery (SRS) Systems Market Insight

The U.K. stereotactic radiosurgery (SRS) systems market is anticipated to grow at a notable CAGR during the forecast period, supported by increasing adoption of advanced radiotherapy technologies and rising demand for non-invasive cancer treatment solutions. Rising awareness regarding precision oncology and improved treatment outcomes is driving demand across healthcare facilities. The country’s well-established healthcare system and expanding oncology infrastructure are accelerating adoption of SRS systems. In addition, increasing investments in advanced medical equipment and treatment capabilities enhance market growth across the value chain.

Germany Stereotactic Radiosurgery (SRS) Systems Market Insight

The Germany stereotactic radiosurgery (SRS) systems market is expected to expand at a considerable CAGR during the forecast period, driven by strong focus on technological innovation and leadership in advanced medical device manufacturing. High emphasis on precision treatment, quality healthcare services, and early adoption of advanced radiotherapy technologies supports the adoption of SRS systems across hospitals and cancer treatment centers. Germany’s focus on research and development promotes the use of high-performance radiosurgery solutions. The integration of advanced imaging and treatment planning technologies aligns with the country’s commitment to improving cancer care outcomes.

Asia-Pacific Stereotactic Radiosurgery (SRS) Systems Market Insight

The Asia-Pacific stereotactic radiosurgery (SRS) systems market is poised to grow at the fastest CAGR during the forecast period of 2026 to 2033, driven by increasing cancer incidence, expanding healthcare infrastructure, and rising investments in radiotherapy technologies. Countries such as China, India, and Japan play a key role in both demand and adoption. Rising disposable income, improving healthcare access, and growing awareness of advanced treatment options are accelerating adoption. In addition, government initiatives promoting cancer care infrastructure and advanced medical technologies further support market growth across the region.

Japan Stereotactic Radiosurgery (SRS) Systems Market Insight

The Japan stereotactic radiosurgery (SRS) systems market is gaining momentum due to increasing focus on advanced medical technologies and precision oncology treatments. Strong emphasis on early diagnosis, high-quality healthcare services, and technological innovation is driving adoption. The growing demand for minimally invasive and high-precision treatment solutions supports long-term market growth. Integration of advanced imaging systems and robotic technologies continues to enhance treatment accuracy and expand application scope across healthcare facilities.

India Stereotactic Radiosurgery (SRS) Systems Market Insight

The India stereotactic radiosurgery (SRS) systems market accounted for a significant revenue share in Asia-Pacific in 2025, attributed to rising cancer prevalence, expanding healthcare infrastructure, and increasing investments in oncology treatment facilities. Growing awareness regarding advanced treatment options and increasing demand for cost-effective, non-invasive procedures are driving adoption. SRS systems are increasingly used across hospitals and specialized cancer centers due to their precision and efficiency. Government initiatives focused on strengthening cancer care and improving access to advanced medical technologies are key factors supporting sustained market expansion in India.

Stereotactic Radiosurgery (SRS) Systems Market Share

The Stereotactic Radiosurgery (SRS) Systems industry is primarily led by well-established companies, including:

• Elekta AB (Sweden)
• Siemens Healthineers AG (Germany)
• Varian Medical Systems, Inc. (U.S.)
• Accuray Incorporated (U.S.)
• Hitachi, Ltd. (Japan)
• Ion Beam Applications S.A. (Belgium)
• ViewRay Technologies, Inc. (U.S.)
• Mevion Medical Systems (U.S.)
• Brainlab AG (Germany)
• Panacea Medical Technologies Pvt. Ltd. (India)
• Koninklijke Philips N.V. (Netherlands)
• GE HealthCare Technologies Inc. (U.S.)
• Medtronic plc (Ireland)
• Mizuho Medical Co., Ltd. (Japan)
• Inomed Medizintechnik GmbH (Germany)
• adeor medical AG (Germany)
• Shinva Medical Instrument Co., Ltd. (China)
• Sumitomo Heavy Industries, Ltd. (Japan)
• ZAP Surgical Systems, Inc. (U.S.)
• Xcision Medical Systems, LLC (U.S.)

What are the Recent Developments in Global Stereotactic Radiosurgery (SRS) Systems Market?

• In December 2025, Elekta AB expanded its stereotactic radiosurgery portfolio by introducing advanced Gamma Knife solutions with enhanced imaging integration and automated workflow capabilities, aimed at improving treatment precision and reducing procedure time for brain tumor therapies
• In October 2025, Accuray Incorporated announced the upgrade of its CyberKnife platform with AI-driven treatment planning and real-time tumor tracking capabilities, designed to enhance accuracy and expand applications across complex oncology cases
• In August 2025, Siemens Healthineers AG launched next-generation image-guided radiotherapy solutions integrated with SRS systems, focusing on improving treatment visualization, workflow efficiency, and patient outcomes
• In June 2025, Varian Medical Systems, Inc. introduced advanced LINAC-based radiosurgery systems with enhanced precision and adaptive radiotherapy capabilities, aimed at improving treatment accuracy and reducing radiation exposure to surrounding healthy tissues
• In March 2024, Brainlab AG expanded its radiosurgery software portfolio by developing advanced treatment planning and navigation solutions, supporting improved clinical decision-making and workflow optimization
• In January 2024, ZAP Surgical Systems, Inc. enhanced its ZAP-X radiosurgery platform with improved gyroscopic beam delivery technology, enabling high-precision, vault-free radiosurgery treatments
• In November 2023, ViewRay Technologies, Inc. strengthened its MR-guided radiotherapy solutions by integrating advanced imaging capabilities into its SRS-compatible systems, improving real-time tumor visualization and treatment adaptability
• In September 2023, Hitachi, Ltd. expanded its proton therapy and radiosurgery solutions with upgraded beam delivery systems, aimed at enhancing precision and expanding oncology treatment applications

SKU-76205